Granules India Limited, announced that Granules Pharmaceuticals, Inc. (GPI), a wholly-owned foreign subsidiary of the company, located in Chantilly, Virginia, USA received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (US FDA).
The GPI facility was inspected by the US FDA from 24th to 28th January 2022 for two of its product applications filed. There were three minor observations during the inspection and GPI had addressed the observations in the stipulated time period.
- Read more about Granules Pharma clears US FDA Audit
- Log in or register to post comments
source https://www.pharmatutor.org/pharma-news/2022/granules-pharma-clears-us-fda-audit
No comments:
Post a Comment